It was medtech IPO day on Wall Street yesterday as a trio of medical device companies priced their initial public offerings.
That’s more than the $60 million midpoint of the range Avinger set last week. The Redwood City, Calif.-based company makes a family of vascular catheters aimed at the peripheral vascular market. AVGR shares weren’t trading yet as of mid-morning today.
Entellus (NSDQ:ENTL) also boosted its offering, from 4.4 million to 4.6 million shares, pricing at the $17 per share midpoint set for a total raise of $78.2 million – also more than the $70 million midpoint set last week. ENTL shares were trading at $21.90 each mid-morning today, down 0.5% on the day but 28.8% over their offering price.
Presbia (NSDQ:LENS), on the other hand, raised less than the $50 million midpoint it set, also last week. Irvine, Calif.-based Presbia, which makes the Flexiview Micro-Lens corneal implant to treat presbyopia, priced its 4.2 million-share IPO at $10, below its $11 to $13 range, for total proceeds of $42 million. LENS shares were trading at $7.72 apiece in mid-morning activity today, down 5.3%.